180 related articles for article (PubMed ID: 26031654)
1. Cutaneous involvement in systemic anaplastic large cell lymphoma.
Kwok C; Salmo E
J Dtsch Dermatol Ges; 2015 Jul; 13(7):693-5. PubMed ID: 26031654
[No Abstract] [Full Text] [Related]
2. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
Isogai R; Fukao M; Kawada A
J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
[TBL] [Abstract][Full Text] [Related]
3. Secondary CNS involvement of ALK-negative anaplastic large cell lymphoma.
Major A; Pan Z; Kamdar M
Am J Hematol; 2017 Nov; 92(11):1267-1268. PubMed ID: 28370436
[No Abstract] [Full Text] [Related]
4. Isolated cutaneous involvement in a child with nodal anaplastic large cell lymphoma.
Mendiratta V; Gandhi N; Rana S; Shukla S;
Indian J Dermatol Venereol Leprol; 2016; 82(1):53-6. PubMed ID: 26728811
[TBL] [Abstract][Full Text] [Related]
5. [22-year-old man with T-cell-lymphoma and new skin lesions].
Kampfenkel T; Schroers R; Kreuter A
Dtsch Med Wochenschr; 2012 Mar; 137(9):429-30. PubMed ID: 22354798
[No Abstract] [Full Text] [Related]
6. [Granulomatous slack skin with anaplastic large cell lymphoma: report of a case].
Xie JJ; Zhou ZQ; Wang Y; Li Y; Zhang RY; Ren YB; Chen B; Zhou GY
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):267-8. PubMed ID: 21616005
[No Abstract] [Full Text] [Related]
7. Systemic anaplastic large cell lymphoma with secondary cutaneous involvement.
Murkute AS; Damle DK; Doshi BR; Belgaumkar VA
Indian J Dermatol Venereol Leprol; 2015; 81(2):208-10. PubMed ID: 25751352
[No Abstract] [Full Text] [Related]
8. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
9. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma.
Dunleavy K; Pittaluga S; Shovlin M; Roschewski M; Lai C; Steinberg SM; Jaffe ES; Wilson WH
Haematologica; 2016 Jan; 101(1):e27-9. PubMed ID: 26518748
[No Abstract] [Full Text] [Related]
11. "Double hit" anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements.
Luo DX; Li W; Ye MT; Yang Y; Tang G; You MJ
Am J Hematol; 2020 Dec; 95(12):1625-1627. PubMed ID: 32833271
[No Abstract] [Full Text] [Related]
12. Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Mandal S; Varma K; Jain S
Cytopathology; 2008 Apr; 19(2):127-9. PubMed ID: 18070116
[No Abstract] [Full Text] [Related]
13. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.
Herrera E; Gallardo M; Bosch R; Cabra B; Aneri V; Sánchez P
J Cutan Pathol; 2002 Mar; 29(3):181-4. PubMed ID: 11972717
[TBL] [Abstract][Full Text] [Related]
14. Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
Kawamoto K; Suzuki T; Kasami T; Kiryu M; Sone H; Miyoshi H; Ohshima K; Takizawa J
Hematol Oncol; 2019 Apr; 37(2):212-214. PubMed ID: 30394560
[No Abstract] [Full Text] [Related]
15. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
[No Abstract] [Full Text] [Related]
16. What is your diagnosis? Cutaneous B-cell lymphoma.
Carlson SW; Aneja S; Honda K; Cooper KD
Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
[No Abstract] [Full Text] [Related]
17. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
Chou WC; Su IJ; Tien HF; Liang DC; Wang CH; Chang YC; Cheng AL
Cancer; 1996 Oct; 78(8):1805-12. PubMed ID: 8859196
[TBL] [Abstract][Full Text] [Related]
18. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
Sheehy O; Catherwood M; Pettengell R; Morris TC
Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
[No Abstract] [Full Text] [Related]
19. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
20. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
